Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cancer Research|February 20, 2004
Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genesUbaradka G Sathyanarayana, Riichiroh Maruyama, Asha Padar, et al.
Cancer Biology & Therapy|March 25, 2015
Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombusRaquibul Hannan, Vitaly Margulis, Stephen G Chun, et al.
Urologic Oncology|April 12, 2015
Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinomaNirmish Singla, Bishoy A Gayed, Aditya Bagrodia, et al.
Plos One|February 26, 2013
Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosisIzabela A Malinowska, Nancy Lee, Vidhya Kumar, et al.
The Journal of Urology|November 27, 2016
A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United StatesNirmish Singla, Dong Fang, Xiaohong Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignantTanja Fehm, Arthur Sagalowsky, Edward Clifford, et al.
Urologic Oncology|November 28, 2017
Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United StatesNirmish Singla, Dong Fang, Xiaohong Su, et al.
Cancer Management and Research|October 29, 2020
The Significance of Preoperative Serum Sodium and Hemoglobin in Outcomes of Upper Tract Urothelial Carcinoma: Multi-Center Analysis Between China and the United StatesDong Fang, Nirmish Singla, Zhengqing Bao, et al.
Oncotarget|July 30, 2016
Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analoguesWei Chen, Jiancheng Zhou, Kaijie Wu, et al.
Cancer|September 5, 2014
Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinomaAhmed Q Haddad, Payal Kapur, Nirmish Singla, et al.
Pageof 4